Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Rosas

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Oncology and Therapy|July 24, 2020
Review of the Agnostic-Type Treatment Approach: Treating Cancer by Mutations, Not by LocationDaniel Rosas, Luis E Raez
International Journal of Molecular Sciences|May 13, 2026
Therapeutic Advances in Non-Small Cell Lung Cancer Harboring <i>EGFR</i> Exon 20 Insertion Mutations: From Molecular Biology to Targeted TherapyDaniel Rosas, Jay Desai, Luis Raez
Journal of Agricultural and Food Chemistry|September 24, 2013
Resin glycosides from the yellow-skinned variety of sweet potato (Ipomoea batatas)Daniel Rosas-Ramírez, Rogelio Pereda-Miranda
Journal of Natural Products|December 23, 2014
Batatins VIII-XI, glycolipid ester-type dimers from Ipomoea batatasDaniel Rosas-Ramírez, Rogelio Pereda-Miranda
International Journal of Molecular Sciences|July 15, 2026
Targeting MET in 2025: From Exon 14 Skipping to MET-Amplified Acquired Resistance in Non-Small Cell Lung CancerAliya Khan, Michael Imeh, Priyanka Barad, et al.
Translational Lung Cancer Research|November 19, 2020
A narrative review of biosimilars: a continued journey from the scientific evidence to practice implementationJorge J García, Luis E Raez, Daniel Rosas
Phytochemistry|April 2, 2011
Batatins III-VI, glycolipid ester-type dimers from Ipomoea batatasDaniel Rosas-Ramírez, Edgar Escalante-Sánchez, Rogelio Pereda-Miranda
Phytochemistry|February 9, 2018
Morning glory resin glycosides as α-glucosidase inhibitors: In vitro and in silico analysisDaniel Rosas-Ramírez, Sonia Escandón-Rivera, Rogelio Pereda-Miranda
Cancers|October 23, 2021
Neuregulin 1 Gene (<i>NRG1</i>). A Potentially New Targetable Alteration for the Treatment of Lung CancerDaniel Rosas, Luis E Raez, Alessandro Russo, et al.
The Journal of Liquid Biopsy|March 3, 2025
Moving liquid biopsies to the Front-line of lung cancer treatment decisionsLuis E Raez, Carlos Carracedo, Daniel Rosas, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Oncology and Therapy|July 24, 2020
Review of the Agnostic-Type Treatment Approach: Treating Cancer by Mutations, Not by LocationDaniel Rosas, Luis E Raez
International Journal of Molecular Sciences|May 13, 2026
Therapeutic Advances in Non-Small Cell Lung Cancer Harboring <i>EGFR</i> Exon 20 Insertion Mutations: From Molecular Biology to Targeted TherapyDaniel Rosas, Jay Desai, Luis Raez
Journal of Agricultural and Food Chemistry|September 24, 2013
Resin glycosides from the yellow-skinned variety of sweet potato (Ipomoea batatas)Daniel Rosas-Ramírez, Rogelio Pereda-Miranda
Journal of Natural Products|December 23, 2014
Batatins VIII-XI, glycolipid ester-type dimers from Ipomoea batatasDaniel Rosas-Ramírez, Rogelio Pereda-Miranda
International Journal of Molecular Sciences|July 15, 2026
Targeting MET in 2025: From Exon 14 Skipping to MET-Amplified Acquired Resistance in Non-Small Cell Lung CancerAliya Khan, Michael Imeh, Priyanka Barad, et al.
Translational Lung Cancer Research|November 19, 2020
A narrative review of biosimilars: a continued journey from the scientific evidence to practice implementationJorge J García, Luis E Raez, Daniel Rosas
Phytochemistry|April 2, 2011
Batatins III-VI, glycolipid ester-type dimers from Ipomoea batatasDaniel Rosas-Ramírez, Edgar Escalante-Sánchez, Rogelio Pereda-Miranda
Phytochemistry|February 9, 2018
Morning glory resin glycosides as α-glucosidase inhibitors: In vitro and in silico analysisDaniel Rosas-Ramírez, Sonia Escandón-Rivera, Rogelio Pereda-Miranda
Cancers|October 23, 2021
Neuregulin 1 Gene (<i>NRG1</i>). A Potentially New Targetable Alteration for the Treatment of Lung CancerDaniel Rosas, Luis E Raez, Alessandro Russo, et al.
The Journal of Liquid Biopsy|March 3, 2025
Moving liquid biopsies to the Front-line of lung cancer treatment decisionsLuis E Raez, Carlos Carracedo, Daniel Rosas, et al.
Pageof 3